Catherine Ramsey
Stock Analyst at Baird
(3.73)
# 733
Out of 5,152 analysts
56
Total ratings
53.49%
Success rate
9.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Outperform | $239 → $257 | $203.03 | +26.58% | 7 | Feb 27, 2026 | |
| CSTL Castle Biosciences | Maintains: Outperform | $41 → $44 | $28.17 | +56.19% | 10 | Feb 27, 2026 | |
| ILMN Illumina | Maintains: Neutral | $105 → $109 | $128.97 | -15.48% | 7 | Oct 31, 2025 | |
| RVTY Revvity | Maintains: Outperform | $122 → $123 | $98.49 | +24.89% | 6 | Oct 28, 2025 | |
| WAT Waters | Maintains: Outperform | $374 → $352 | $319.04 | +10.33% | 11 | Jul 16, 2025 | |
| TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $48.06 | -8.45% | 7 | May 6, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $512.69 | +29.71% | 2 | Nov 1, 2022 | |
| A Agilent Technologies | Maintains: Outperform | $155 → $160 | $120.54 | +32.74% | 5 | Aug 17, 2022 | |
| EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $103.50 | -27.54% | 1 | Aug 3, 2022 |
Natera
Feb 27, 2026
Maintains: Outperform
Price Target: $239 → $257
Current: $203.03
Upside: +26.58%
Castle Biosciences
Feb 27, 2026
Maintains: Outperform
Price Target: $41 → $44
Current: $28.17
Upside: +56.19%
Illumina
Oct 31, 2025
Maintains: Neutral
Price Target: $105 → $109
Current: $128.97
Upside: -15.48%
Revvity
Oct 28, 2025
Maintains: Outperform
Price Target: $122 → $123
Current: $98.49
Upside: +24.89%
Waters
Jul 16, 2025
Maintains: Outperform
Price Target: $374 → $352
Current: $319.04
Upside: +10.33%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $48.06
Upside: -8.45%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $512.69
Upside: +29.71%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $120.54
Upside: +32.74%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $103.50
Upside: -27.54%